Shandong Jincheng Pharmaceutical Group Co., Ltd
SHZ: 300233.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Jiaquan Li
- Employees
- 3,657
- Headquarters
- Zibo, China
- IPO year
- 2011
- Market cap
- CN¥6.1B
- Website
- https://www.jinchengpharm.com
Loading 300233…
Loading profile data…Frequently asked questions about 300233
What does Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) do?
Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers active pharmaceutical ingredients, biopharmaceuticals, medical intermediates, fine chemicals, finished dosages, and pharmaceutical prod...
Where does 300233.SZ trade?
Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300233.SZ in?
Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) operates in the Basic Materials sector, specifically in the Chemicals industry.
Who is the CEO of Shandong Jincheng Pharmaceutical Group Co., Ltd?
Jiaquan Li is the chief executive officer of Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ).
Where is Shandong Jincheng Pharmaceutical Group Co., Ltd headquartered?
Shandong Jincheng Pharmaceutical Group Co., Ltd is headquartered in China.
Does 300233.SZ pay a dividend?
Yes — Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300233.SZ go public?
Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) completed its initial public offering in 2011.